Advertisement

Cerebral Magnetic Resonance Spectroscopy Demonstrates Long-Term Effect of Bone Marrow Transplantation in α-Mannosidosis

  • Else R. Danielsen
  • Allan M. Lund
  • Carsten Thomsen
Case Report
Part of the JIMD Reports book series (JIMD, volume 11)

Abstract

α-Mannosidosis, OMIM #248500, is an autosomal recessive lysosomal storage disease caused by acidic α-mannosidase deficiency. Treatment options include bone marrow transplantation (BMT) and, possibly in the future, enzyme replacement therapy. Brain magnetic resonance spectroscopy (MRS) enables non-invasive monitoring of cerebral treatment effect. Accumulated cerebral mannose-containing oligosaccharides were demonstrated by MRS in a patient who at age 2 years and 11 months received a BMT from a haploidentical non-carrier sibling. The cerebral mannose-containing oligosaccharides had disappeared as early as 9½ months after BMT. MRS furthermore demonstrated the persistent treatment effect at regular intervals up to 5½ years after BMT. MRS is a non-invasive tool that can demonstrate the effect of BMT treatment. Likewise, MRS may be used to demonstrate the cerebral effect of other potential treatments such as enzyme replacement therapy.

Keywords

Apparent Diffusion Coefficient Bone Marrow Transplantation Magnetic Resonance Spectroscopy Enzyme Replacement Therapy Broad Resonance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Supplementary material

313738_1_En_221_MOESM1_ESM.pdf (189 kb)
1H MR spectroscopy of gray and white matter in carbon monoxide poisoning (PDF 189 kb)
313738_1_En_221_MOESM2_ESM.pdf (243 kb)
Axonal_injury (PDF 243 kb)
313738_1_En_221_MOESM3_ESM.pdf (189 kb)
Dalsgaard 2004 J Physiol (PDF 189 kb)
313738_1_En_221_MOESM4_ESM.pdf (109 kb)
Fatal encephalopathy after an isolated overdose of cocaine (PDF 110 kb)
313738_1_En_221_MOESM5_ESM.pdf (173 kb)
MELAS3256CT (PDF 174 kb)
313738_1_En_221_MOESM6_ESM.pdf (462 kb)
PLP1 (PDF 462 kb)

References

  1. Abraham D, Daniel P, Dell A et al (1986) Structural analysis of the major urinary oligosaccharides in feline alpha-mannosidosis. Biochem J 233(3):899–904PubMedGoogle Scholar
  2. Ara JR, Mayayo E, Marzo ME et al (1999) Neurological impairment in alpha-mannosidosis: a longitudinal clinical and MRI study of a brother and sister. Childs Nerv Syst 15(8):369–371PubMedCrossRefGoogle Scholar
  3. Avenarius DF, Svendsen JS, Malm D (2011) Proton nuclear magnetic resonance spectroscopic detection of oligomannosidic n glycans in alpha-mannosidosis: a method of monitoring treatment. J Inherit Metab Dis 34(5):1023–1027PubMedCrossRefGoogle Scholar
  4. Blanz J, Stroobants S, Lüllmann-Rauch R et al (2008) Reversal of peripheral and central neural storage and ataxia after recombinant enzyme replacement therapy in alpha-mannosidosis mice. Hum Mol Genet 17:3437–3445PubMedCrossRefGoogle Scholar
  5. Chester MA, Lundblad A, Öckerman PA et al (1982) Mannosidosis. In: Durand P, O'Brian J (eds) Genetic errors of glycoprotein metabolism. Edi-Ermes, Milan, Italy, pp 89–120CrossRefGoogle Scholar
  6. Crawley AC, King B, Berg T et al (2006) Enzyme replacement therapy in alpha-mannosidosis guinea-pigs. Mol Genet Metab 89(1–2):48–57PubMedCrossRefGoogle Scholar
  7. Dietemann JL, Filippi de la Palavesa MM, Tranchant C et al (1990) MR findings in mannosidosis. Neuroradiology 32(6):485–487PubMedCrossRefGoogle Scholar
  8. Elberling TV, Danielsen ER, Rasmussen AK et al (2003) Reduced myo-inositol and total choline measured with cerebral MRS in acute thyrotoxic Graves’ disease. Neurology 60(1):142–145PubMedCrossRefGoogle Scholar
  9. Gutschalk A, Harting I, Cantz M et al (2004) Adult alpha-mannosidosis: clinical progression in the absence of demyelination. Neurology 63:1744–1746PubMedCrossRefGoogle Scholar
  10. Hård K, Mekking A, Kamerling JP et al (1991) Different oligosaccharides accumulate in the brain and urine of a cat with alpha-mannosidosis: structure determination of five brain-derived and seventeen urinary oligosaccharides. Glycoconj J 8(1):17–28PubMedCrossRefGoogle Scholar
  11. Magnitsky S, Vite CH, Delikatny EJ et al (2010) Magnetic resonance spectroscopy of the occipital cortex and the cerebellar vermis distinguishes individual cats affected with alpha-mannosidosis from normal cats. NMR Biomed 23(1):74–79PubMedCrossRefGoogle Scholar
  12. Malm D, Nilssen Ø (2008) Alpha-mannosidosis. Orphanet J Rare Dis 3:21PubMedCrossRefGoogle Scholar
  13. Niemann S, Beck M, Seidel G et al (1996) Neurology of adult alpha-mannosidosis. J Neurol Neurosurg Psychiatry 61(1):116–117PubMedCrossRefGoogle Scholar
  14. Provencher SW (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30(6):672–679PubMedCrossRefGoogle Scholar
  15. Roces DP, Lüllmann-Rauch R, Peng J et al (2004) Efficacy of enzyme replacement therapy in alpha-mannosidosis mice: a preclinical animal study. Hum Mol Genet 13(18):1979–1988PubMedCrossRefGoogle Scholar
  16. Strecker G, Fournet B, Bouquelet S et al (1976) Chemistry of urinary mannosides excreted in mannosidosis 58(5):579–586Google Scholar
  17. Takahashi Y, Sukegawa K, Aoki M et al (2001) Evaluation of accumulated mucopolysaccharides in the brain of patients with mucopolysaccharidoses by 1H-magnetic resonance spectroscopy before and after bone marrow transplantation. Pediatr Res 49(3):349–355PubMedCrossRefGoogle Scholar
  18. Van Halbeek H, Dorland L, Veldink GA et al (1980) A 500 MHz 1H NMR study of urinary oligosaccharides from patients with mannosidosis. FEBS Lett 121(1):71–77PubMedCrossRefGoogle Scholar
  19. Vite CH, Magnitsky S, Aleman D et al (2008) Apparent diffusion coefficient reveals gray and white matter disease, and T2 mapping detects white matter disease in the brain in feline alpha-mannosidosis. AJNR Am J Neuroradiol 29(2):308–313PubMedCrossRefGoogle Scholar
  20. Vite CH, McGowan JC, Braund KG et al (2001) Histopathology, electrodiagnostic testing, and magnetic resonance imaging show significant peripheral and central nervous system myelin abnormalities in the cat model of alpha-mannosidosis. J Neuropathol Exp Neurol 60(8):817–828PubMedGoogle Scholar

Copyright information

© SSIEM and Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Else R. Danielsen
    • 1
  • Allan M. Lund
    • 2
  • Carsten Thomsen
    • 1
  1. 1.Copenhagen ØDenmark
  2. 2.Copenhagen ØDenmark

Personalised recommendations